1158749-85-9 Usage
Explanation
Different sources of media describe the Explanation of 1158749-85-9 differently. You can refer to the following data:
1. The molecular formula represents the number of atoms of each element present in a molecule of the compound.
2. The CAS (Chemical Abstracts Service) number is a unique identifier assigned to a specific chemical compound.
3. It is used as a starting material or building block in the synthesis of pharmaceuticals.
4. The compound exists in a solid state and has a white to off-white color with a crystalline structure.
5. The compound does not dissolve in water but can dissolve in certain organic solvents, such as alcohols, ketones, or ethers.
6. Due to potential hazards associated with its use, it is important to follow safety guidelines and handle the compound with care to minimize risks.
7. It is crucial to follow established safety protocols and guidelines when working with this chemical to ensure the safety of the user and the environment.
Common use
Pharmaceutical intermediate
Physical state
White to off-white crystalline solid
Solubility
Insoluble in water, soluble in organic solvents
Safety precautions
Different sources of media describe the Safety precautions of 1158749-85-9 differently. You can refer to the following data:
1. Handle and use in a controlled manner
2. In accordance with safety guidelines
Check Digit Verification of cas no
The CAS Registry Mumber 1158749-85-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,5,8,7,4 and 9 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1158749-85:
(9*1)+(8*1)+(7*5)+(6*8)+(5*7)+(4*4)+(3*9)+(2*8)+(1*5)=199
199 % 10 = 9
So 1158749-85-9 is a valid CAS Registry Number.
1158749-85-9Relevant articles and documents
Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2 H-benzo[ b][1,4]oxazin-6-yl Moiety
Ikeda, Shuhei,Sugiyama, Hideyuki,Tokuhara, Hidekazu,Murakami, Masataka,Nakamura, Minoru,Oguro, Yuya,Aida, Jumpei,Morishita, Nao,Sogabe, Satoshi,Dougan, Douglas R.,Gay, Sean C.,Qin, Ling,Arimura, Naoto,Takahashi, Yasuko,Sasaki, Masako,Kamada, Yusuke,Aoyama, Kazunobu,Kimoto, Kouya,Kamata, Makoto
, p. 11014 - 11044 (2021/08/24)
The therapeutic potential of monoacylglycerol lipase (MAGL) inhibitors in central nervous system-related diseases has attracted attention worldwide. However, the availability of reversible-type inhibitor is still limited to clarify the pharmacological eff
